Literature DB >> 18521266

Symptoms and their Relationship to Disability Following Treatment for Lower Extremity Tumours.

A M Davis1, S Punniyamoorthy, A M Griffin, J S Wunder, R S Bell.   

Abstract

Purpose. The aims of this study were to describe the symptoms experienced by patients in the first year following treatment for lower extremity sarcoma by limb conservation and to describe the relationship between symptoms and physical disability.Subjects. Eighty consecutive patients treated for primary bone or soft tissue sarcoma (STS) of the lower limb who were treated with limb preservation surgery.Methods. Subjects were evaluated by questionnaire at 6 weeks, and 3, 6, and 12 months post surgery. They identified whether they experienced any of the following symptoms: pain, stiffness, fatigue, weakness, limited range of motion, or swelling.The Toronto Extremity Salvage Score (TESS), a measure of physical disability, was also completed. Frequency of symptoms over time was calculated and change was evaluated using the Cochrane test. The relationship of symptoms to disability was analyzed with regression methods.Results. The mean age was 43.0, SD=20.4 with a gender ratio of 1:1. There were 38 bone tumours and 42 STS.The most frequently reported symptoms were: stiffness 48 (60%), weakness 41 (51%), fatigue 26 (33%), and pain 25 (31%) at 6 weeks. Stiffness and fatigue decreased and plateaued by 3 months. Complaints of weakness and pain continued to decrease over time. At 6 weeks, pain, stiffness, weakness and limited motion predicted disability in both univariate and multivariate analyses. At 12 months, pain, stiffness, fatigue, weakness and limited motion were significant predictors of the TESS in univariate analysis with only pain, stiffness and limited motion significant predictors in the multivariate model.Discussion. Pain, stiffness, fatigue, weakness and limited motion are common symptoms with stiffness and weakness decreasing significantly over time. The symptoms predictive of disability differ between the acute and late phases of recovery.

Entities:  

Year:  1999        PMID: 18521266      PMCID: PMC2395419          DOI: 10.1080/13577149977677

Source DB:  PubMed          Journal:  Sarcoma        ISSN: 1357-714X


  12 in total

1.  Therapeutic and functional results of limb salvage to treat sarcomas of the forearm and hand.

Authors:  A M Wexler; F R Eilber; T A Miller
Journal:  J Hand Surg Am       Date:  1988-03       Impact factor: 2.230

2.  Physical and psychosocial outcomes of midlife and older women following surgery and adjuvant therapy for breast cancer.

Authors:  G K Wyatt; L L Friedman
Journal:  Oncol Nurs Forum       Date:  1998-05       Impact factor: 2.172

3.  Soft tissue sarcoma: functional outcome after wide local excision and radiation therapy.

Authors:  M H Lampert; L H Gerber; E Glatstein; S A Rosenberg; J V Danoff
Journal:  Arch Phys Med Rehabil       Date:  1984-08       Impact factor: 3.966

4.  Limb function following conservation treatment of adult soft tissue sarcoma.

Authors:  M H Robinson; L Spruce; R Eeles; I Fryatt; C L Harmer; J M Thomas; G Westbury
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

5.  Evaluating functional outcome in patients with lower extremity sarcoma.

Authors:  A M Davis; R S Bell; E M Badley; K Yoshida; J I Williams
Journal:  Clin Orthop Relat Res       Date:  1999-01       Impact factor: 4.176

6.  Acute and long-term effects on limb function of combined modality limb sparing therapy for extremity soft tissue sarcoma.

Authors:  S F Stinson; T F DeLaney; J Greenberg; J C Yang; M H Lampert; J E Hicks; D Venzon; D E White; S A Rosenberg; E J Glatstein
Journal:  Int J Radiat Oncol Biol Phys       Date:  1991-11       Impact factor: 7.038

7.  Measurement of fatigue in cancer patients: development and validation of the Fatigue Symptom Inventory.

Authors:  D M Hann; P B Jacobsen; L M Azzarello; S C Martin; S L Curran; K K Fields; H Greenberg; G Lyman
Journal:  Qual Life Res       Date:  1998-05       Impact factor: 4.147

8.  Correlation between the measures of impairment, according to the modified system of the American Medical Association, and function.

Authors:  M L McCarthy; M P McAndrew; E J MacKenzie; A R Burgess; B M Cushing; B J Delateur; G J Jurkovich; J A Morris; M F Swiontkowski
Journal:  J Bone Joint Surg Am       Date:  1998-07       Impact factor: 5.284

9.  Beyond body image: the experience of breast cancer.

Authors:  M Z Cohen; D L Kahn; R H Steeves
Journal:  Oncol Nurs Forum       Date:  1998-06       Impact factor: 2.172

10.  Local control of soft tissue sarcoma of the extremity: the experience of a multidisciplinary sarcoma group with definitive surgery and radiotherapy.

Authors:  A N Wilson; A Davis; R S Bell; B O'Sullivan; C Catton; F Madadi; R Kandel; V L Fornasier
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

View more
  5 in total

1.  Distal femoral osteoarticular allografts: long-term survival, but frequent complications.

Authors:  Patrick C Toy; Jeremy R White; Mark T Scarborough; William F Enneking; C Parker Gibbs
Journal:  Clin Orthop Relat Res       Date:  2010-11       Impact factor: 4.176

Review 2.  [Long-term functional results after sarcoma resection].

Authors:  H-U Steinau; J Hauser; F Farzaliyev; L Podleska
Journal:  Chirurg       Date:  2014-03       Impact factor: 0.955

3.  Cured of primary bone cancer, but at what cost: a qualitative study of functional impairment and lost opportunities.

Authors:  Lena Fauske; Oyvind S Bruland; Ellen Karine Grov; Hilde Bondevik
Journal:  Sarcoma       Date:  2015-04-09

4.  Changes in the body image of bone sarcoma survivors following surgical treatment--A qualitative study.

Authors:  Lena Fauske; Geir Lorem; Ellen K Grov; Hilde Bondevik
Journal:  J Surg Oncol       Date:  2015-12-29       Impact factor: 3.454

5.  Management of soft-tissue sarcomas; treatment strategies, staging, and outcomes.

Authors:  Eyal M Ramu; Matthew T Houdek; Christian E Isaac; Colleen I Dickie; Peter C Ferguson; Jay S Wunder
Journal:  SICOT J       Date:  2017-03-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.